Division of Pediatric Urology, UCLA Mattel Children's Hospital, Los Angeles ,CA; Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA.
Division of Pediatric Urology, Children's Hospital of Orange County, Orange, CA.
Urology. 2022 Nov;169:196-201. doi: 10.1016/j.urology.2022.07.025. Epub 2022 Jul 28.
Single-layer ACell Cytal matrix (ACell Inc, Columbia, MD) is a commercially available, acellular scaffold derived from porcine bladder epithelial basement membrane and tunica propria. We describe our initial experience using Cytal as corporal graft in pediatric patients who underwent correction of ventral curvature in proximal hypospadias repair.
A retrospective review of a single-institution, 4 surgeon hypospadias database was performed between January 2020 and December 2021. Outcomes assessed were postoperative recurrent ventral curvature, corporal diverticulum, scarring on corporoplasty site on physical exam, and parental reports of atypical adverse effects.
Ten males underwent correction of ventral curvature with Cytal as corporal graft for correction of ventral curvature were identified. All completed planned operations. Median age was 18.6 months (IQR 14.6-27.0). Median follow up was 14.1 months (IQR 8.9-16.5). Mean ventral curvature after degloving was 80 ± 50 degrees. All patients had straight erections. Nine of the 10 patients had straight erections verified at a subsequent artificial erection test at least 6 months from the corporoplasty (90%). The remaining patient underwent a double face onlay-tube-onlay transverse island preputial flap as a single-stage hypospadias repair and did not require any additional procedures. He had straight erections per parental history. None developed corporal diverticulum or demonstrated induration at site of corporoplasty on physical exam. There were no parental reports of atypical adverse systemic effects.
In the short term, single-layer Cytal is effective as corporal graft for correction of ventral curvature in proximal hypospadias repairs without incurring additional donor site morbidity.
单层 ACell Cytal 基质(ACell Inc,哥伦比亚,MD)是一种市售的无细胞支架,源自猪膀胱上皮基底膜和固有层。我们描述了我们在接受近端尿道下裂修复的儿童患者中使用 Cytal 作为 corporal 移植物的初步经验。
对 2020 年 1 月至 2021 年 12 月期间单机构、4 位外科医生尿道下裂数据库进行回顾性分析。评估的结果是术后复发性腹侧弯曲、 corporal 憩室、 corporoplasty 部位的疤痕在体格检查中的表现,以及家长报告的非典型不良反应。
确定了 10 名男性接受了 Cytal 作为 corporal 移植物矫正腹侧弯曲以矫正腹侧弯曲。所有患者均完成了计划手术。中位年龄为 18.6 个月(IQR 14.6-27.0)。中位随访时间为 14.1 个月(IQR 8.9-16.5)。去上皮化后平均腹侧弯曲为 80 ± 50 度。所有患者均有笔直的勃起。在 corporoplasty 后至少 6 个月进行的后续人工勃起试验中,9 名患者中有 9 名患者的勃起笔直(90%)。另一名患者接受了双层游离皮瓣-管-横向岛状包皮瓣作为一期尿道下裂修复术,不需要任何其他手术。根据家长的病史,他的勃起笔直。体格检查中,没有患者出现 corporal 憩室或 corporoplasty 部位硬结。没有家长报告非典型的全身不良反应。
在短期内,单层 Cytal 作为 corporal 移植物矫正近端尿道下裂的腹侧弯曲是有效的,不会增加供体部位的发病率。